Pigmentation disorders: Hyperpigmentation and hypopigmentation

Clinics in Dermatology

Volumn 32, Issue 1, 2014, Pages 66-72

  Nicolaidou, Electra ^a   Katsambas, Andreas D ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANTIDEPRESSANT AGENT; ANTIMALARIAL AGENT; CALCINEURIN INHIBITOR; CLOFAZIMINE; CORTICOSTEROID; DAPSONE; DESIPRAMINE; HYDROQUINONE; IMIPRAMINE; KERATOLYTIC AGENT; PHENOTHIAZINE; PIMECROLIMUS; RETINOIC ACID; TACROLIMUS;

ADDISON DISEASE; CHLOASMA; CONTACT DERMATITIS; DISEASE CLASSIFICATION; ERYTHEMA DYSCHROMICUM PERSTANS; ERYTHEMA STREPTOGENES; ERYTHROMELANOSIS FOLLICULARIS FACIEI; HEMOCHROMATOSIS; HISTOPATHOLOGY; HUMAN; HYPERPIGMENTATION; HYPOPIGMENTATION; LOW LEVEL LASER THERAPY; NOTE; PHOTOCHEMOTHERAPY; PHOTODERMATOSIS; PHOTOTHERAPY; PIEBALDISM; PIGMENT DISORDER; POIKILODERMA; PORPHYRIA CUTANEA TARDA; PRIORITY JOURNAL; SKIN PROTECTION; SKIN TRANSPLANTATION; SUN EXPOSURE; SUNLIGHT PROTECTION; ULTRAVIOLET B RADIATION; VITILIGO;

DERMATITIS, PHOTOTOXIC; DRUG ERUPTIONS; FACIAL DERMATOSES; HUMANS; HYPERPIGMENTATION; HYPOPIGMENTATION;

EID: 84889608633     PISSN: 0738081X     EISSN: 18791131     Source Type: Journal    
DOI: 10.1016/j.clindermatol.2013.05.026     Document Type: Note

References (32)

1. Katsambas A.D., Stratigos A.J., Lotti T.M. Melasma. European Handbook of Dermatological Treatments 2003, 336-341. Springer, Berlin, Germany. 2nd ed. A.D. Katsambas, T.M. Lotti (Eds.).
2. Sheth V.M., Pandya A.G. Melasma: a comprehensive update. Part I. J Am Acad Dermatol 2011, 65:689-697.
3. Katsambas A., Antoniou C. Melasma. Classification and treatment. J Eur Acad Dermatol Venereol 1995, 4:217-223.
4. Grimes P.E., Yamada N., Bhawan J. Light microscopic, immunohistochemical, and ultrastructural alterations in patients with melasma. Am J Dermatopathol 2005, 27:96-101.
5. Kang W.H., Yoon K.H., Lee E.S., et al. Melasma: histopathological characteristics in 56 Korean patients. Br J Dermatol 2002, 146:228-237.
6. Sheth V.M., Pandya A.G. Melasma: a comprehensive update. Part II. J Am Acad Dermatol 2011, 65:699-714.
7. Riehl G. Uber eine eigenartige melanose. Wien Klin Wochensschr 1917, 30:280-281.
8. Sugai T., Takahashi Y., Takagi T. Pigmented cosmetic dermatitis and coal tar dyes. Contact Dermatitis 1977, 3:249-256.
9. Kozuka T., Tashiro M., Sano S., et al. Brilliant lake red R as a cause of pigmented contact dermatitis. Contact Dermatitis 1979, 5:297-304.
10. Serrano G., Pujol C., Cuadra J., Gallo S., Aliaga A. Riehl's melanosis: pigmented contact dermatitis caused by fragrances. J Am Acad Dermatol 1989, 21(5 Pt 2):1057-1060.
11. Trattner A., David M. Pigmented contact dermatitis from topical minoxidil 5%. Contact Dermatitis 2002, 46:246.
12. Inui S., Nakajima T., Toda N., Itami S. Pigmented contact dermatitis due to therapeutic sensitizer as complication of contact immunotherapy in alopecia areata. J Dermatol 2010, 37:888-893.
13. Watt T.L., Kaiser J.S. Erythromelanosis follicularis faciei et colli. A case report. J Am Acad Dermatol 1981, 5:533-534.
14. Warren F.M., Davis L.S. Erythromelanosis follicularis faciei in women. J Am Acad Dermatol 1995, 32(5 Pt 2):863-866.
15. Yanez S., Velasco J.A., Gonzales M.P. Familial erythromelanosis follicularis faciei et colli: an autosomal recessive mode of inheritance. Clin Exp Dermatol 1993, 18:283-285.
16. Kim M.G., Hong S.J., Son S.J., et al. Quantitative histopathologic findings of erythromelanosis follicularis faciei et colli. J Cutan Pathol 2001, 28:160-164.
17. Schwartz R.A. Erythema dyschromicum perstans: the continuing enigma of Cinderella or ashy dermatosis. Int J Dermatol 2004, 43:230-232.
18. Torrelo A., Zaballos P., Colmenero I., et al. Erythema dyschromicum perstans in children: a report of 14 cases. J Eur Acad Dermatol Venereol 2005, 19:422-426.
19. Baranda L., Torres-Alvarez B., Cortes-Franco R., et al. Involvement of cell adhesion and activation molecules in the pathogenesis of erythema dyschromicum perstans (ashy dermatitis). The effect of clofazimine therapy. Arch Dermatol 1997, 133:325-329.
20. Tlougan B.E., Gonzalez M.E., Mandal R.V., Kundu R.V., Skopicki D. Erythema dyschromicum perstans. Dermatol Online J 2010, 16:17.
21. Katoulis A.C., Stavrianeas N.G., Georgala S., et al. Poikiloderma of Civatte: a clinical and epidemiological study. J Eur Acad Dermatol Venereol 2005, 19:444-448.
22. Katoulis A.C., Stavrianeas N.G., Katsarou A., et al. Evaluation of the role of contact sensitization and photosensitivity in the pathogenesis of poikiloderma of Civatte. Br J Dermatol 2002, 147:493-497.
23. Katoulis A.C., Stavrianeas N.G., Georgla S., et al. Familial cases of poikiloderma of Civatte: genetic implications in its pathogenesis?. Clin Exp Dermatol 1999, 24:385-387.
24. Tierney E.P., Hanke C.W. Treatment of poikiloderma of Civatte with ablative fractional laser resurfacing: prospective study and review of the literature. J Drugs Dermatol 2009, 8:527-534.
25. Dereure O. Drug-induced skin pigmentation. Am J Clin Dermatol 2001, 2:253-262.
26. Nicolaidou E., Antoniou C., Miniati A., et al. Childhood- and later-onset vitiligo have diverse epidemiologic and clinical characteristics. J Am Acad Dermatol 2012, 66:954-958.
27. Alikhan A., Felsten L.M., Daly M., Petronic-Rosic V. Vitiligo: a comprehensive overview. Part I. Introduction, epidemiology, quality of life, diagnosis, differential diagnosis, associations, histopathology, etiology, and work-up. J Am Acad Dermatol 2011, 65:473-491.
28. Gawkrodger D.J., Ormerod A.D., Shaw L., et al. Guideline for the diagnosis and management of vitiligo. Br J Dermatol 2008, 159:1051-1076.
29. Felsten L.M., Alikhan A., Petronic-Rosic V. Vitiligo: a comprehensive overview. Part II: treatment options and approach to treatment. J Am Acad Dermatol 2011, 65:493-514.
30. Nicolaidou E., Antoniou C., Stratigos A.J., Stefanaki C., Katsambas A.D. Efficacy, predictors of response, and long-term follow-up in patients with vitiligo treated with narrowband UVB phototherapy. J Am Acad Dermatol 2007, 56:274-278.
31. Nicolaidou E., Antoniou C., Stratigos A., Katsambas A. Narrowband ultraviolet B phototherapy and 308-nm excimer laser in the treatment of vitiligo: a review. J Am Acad Dermatol 2009, 6:470-477.
32. Spritz R.A. The molecular basis of human piebaldism. Pigment Cell Res 1992, 5:340-343.